1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity (Q43759915)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity |
scientific article |
Statements
1 reference
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity (English)
1 reference
Hale JJ
1 reference
Budhu RJ
1 reference
Holson EB
1 reference
Finke PE
1 reference
Oates B
1 reference
Mills SG
1 reference
MacCoss M
1 reference
Gould SL
1 reference
DeMartino JA
1 reference
Springer MS
1 reference
Siciliano S
1 reference
Malkowitz L
1 reference
Schleif WA
1 reference
Hazuda D
1 reference
Miller M
1 reference
Kessler J
1 reference
Danzeisen R
1 reference
Holmes K
1 reference
Lineberger J
1 reference
Carella A
1 reference
Carver G
1 reference
Emini E
1 reference
1 October 2001
1 reference
1 reference
11
1 reference
20
1 reference
2741-2745
1 reference
Identifiers
1 reference
1 reference